Freeline Therapeutics Holdings PLC (DELISTED) (FRLN:DL)
6.49
USD |
NASDAQ |
Feb 16, 16:00
Freeline Therapeutics Holdings Enterprise Value : -0.9951M for Feb. 29, 2024
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Adaptimmune Therapeutics Plc | 25.53M |
| Akari Therapeutics Plc | 10.41M |
| Biodexa Pharmaceuticals Plc | -- |
| Verona Pharma Plc (DELISTED) | 9.054B |
| NuCana Plc | -25.07M |
Enterprise Value Related Metrics
| Profit Margin (Quarterly) | -241.8K% |
| Earnings Yield | -175.9% |